Pemphigoid gestationis: Treatment with immunoapheresis

Stefan Wöhrl; Alexandra Geusau; Franz Karlhofer; Kurt Derfler; Georg Stingl; Detlef Zillikens

doi:10.1046/j.1610-0387.2003.t01-1-03509.x

Pemphigoid gestationis: Treatment with immunoapheresis

Stefan Wöhrl^*, Alexandra Geusau, Franz Karlhofer, Kurt Derfler, Georg Stingl, Detlef Zillikens

^*Corresponding author for this work

Clinic of Dermatology, Allergology and Venerology

University of Vienna

32 Citations (Scopus)

Abstract

Background: Pemphigoid (herpes) gestationis is a rare blistering disease of pregnancy. Topical and systemic corticosteroids and antihistamines are usually sufficient for treatment. Case report: A patient suffering from severe, therapy-resistant pemphigoid gestationis was successfully treated with the additional use of six sessions of immunoapheresis. Systemic corticosteroids could be tapered and serum autoantibody levels to bullous pemphigoid antigen 2 (BPAG2 = BP180) significantly dropped during this treatment. Conclusion: Immunoapheresis represents a helpful therapeutic option with few side effects for severe cases of pemphigoid gestationis, unresponsive to conventional treatment.

Original language	English
Journal	JDDG - Journal of the German Society of Dermatology
Volume	1
Issue number	2
Pages (from-to)	126-130
Number of pages	5
ISSN	1610-0379
DOIs	https://doi.org/10.1046/j.1610-0387.2003.t01-1-03509.x
Publication status	Published - 01.02.2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1046/j.1610-0387.2003.t01-1-03509.x

Cite this

@article{0d3549efffa34af1b435997bd33955bd,

title = "Pemphigoid gestationis: Treatment with immunoapheresis",

abstract = "Background: Pemphigoid (herpes) gestationis is a rare blistering disease of pregnancy. Topical and systemic corticosteroids and antihistamines are usually sufficient for treatment. Case report: A patient suffering from severe, therapy-resistant pemphigoid gestationis was successfully treated with the additional use of six sessions of immunoapheresis. Systemic corticosteroids could be tapered and serum autoantibody levels to bullous pemphigoid antigen 2 (BPAG2 = BP180) significantly dropped during this treatment. Conclusion: Immunoapheresis represents a helpful therapeutic option with few side effects for severe cases of pemphigoid gestationis, unresponsive to conventional treatment.",

author = "Stefan W{\"o}hrl and Alexandra Geusau and Franz Karlhofer and Kurt Derfler and Georg Stingl and Detlef Zillikens",

year = "2003",

month = feb,

day = "1",

doi = "10.1046/j.1610-0387.2003.t01-1-03509.x",

language = "English",

volume = "1",

pages = "126--130",

journal = "JDDG - Journal of the German Society of Dermatology",

issn = "1610-0379",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "2",

}

TY - JOUR

T1 - Pemphigoid gestationis: Treatment with immunoapheresis

AU - Wöhrl, Stefan

AU - Geusau, Alexandra

AU - Karlhofer, Franz

AU - Derfler, Kurt

AU - Stingl, Georg

AU - Zillikens, Detlef

PY - 2003/2/1

Y1 - 2003/2/1

N2 - Background: Pemphigoid (herpes) gestationis is a rare blistering disease of pregnancy. Topical and systemic corticosteroids and antihistamines are usually sufficient for treatment. Case report: A patient suffering from severe, therapy-resistant pemphigoid gestationis was successfully treated with the additional use of six sessions of immunoapheresis. Systemic corticosteroids could be tapered and serum autoantibody levels to bullous pemphigoid antigen 2 (BPAG2 = BP180) significantly dropped during this treatment. Conclusion: Immunoapheresis represents a helpful therapeutic option with few side effects for severe cases of pemphigoid gestationis, unresponsive to conventional treatment.

AB - Background: Pemphigoid (herpes) gestationis is a rare blistering disease of pregnancy. Topical and systemic corticosteroids and antihistamines are usually sufficient for treatment. Case report: A patient suffering from severe, therapy-resistant pemphigoid gestationis was successfully treated with the additional use of six sessions of immunoapheresis. Systemic corticosteroids could be tapered and serum autoantibody levels to bullous pemphigoid antigen 2 (BPAG2 = BP180) significantly dropped during this treatment. Conclusion: Immunoapheresis represents a helpful therapeutic option with few side effects for severe cases of pemphigoid gestationis, unresponsive to conventional treatment.

UR - https://www.scopus.com/pages/publications/18244412523

U2 - 10.1046/j.1610-0387.2003.t01-1-03509.x

DO - 10.1046/j.1610-0387.2003.t01-1-03509.x

M3 - Journal articles

C2 - 16285180

AN - SCOPUS:18244412523

SN - 1610-0379

VL - 1

SP - 126

EP - 130

JO - JDDG - Journal of the German Society of Dermatology

JF - JDDG - Journal of the German Society of Dermatology

IS - 2

ER -

Pemphigoid gestationis: Treatment with immunoapheresis

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this